FDA UDI In Commercial Distribution 🇺🇸 United States

Endomysium (Primate esophagus)

DI: 00845533002011 · Model: 5396EL · ZEUS SCIENTIFIC, INC.
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1

Let the assistant research this device

The Research Assistant compiles product codes, classification, clearances and adverse events for this device — and cites every record.

Free to try · every answer cites its records

Basic Information

Brand Name
Endomysium (Primate esophagus)
Primary DI
00845533002011
Version / Model
5396EL
Catalog Number
5396EL
Company Name
ZEUS SCIENTIFIC, INC.
Labeler DUNS
080953946
Distribution Status
In Commercial Distribution
Device Count in Pkg
1
Record Status
Published
Publish Date
2025-10-17
Public Version
1
Public Version Date
2025-10-27
Public Version Status
New
Public Device Record Key
01dbbeb8-39a0-4524-a950-c090ff43727f

Device Description

Indirect fluorescent assay (IFA) for anti-endomysial antibodies has proven to be a good method to screen for Celiac disease. Endomysial antibodies of the IgA subclass (IgA EmA) react with the reticulin component of the endomysium of the smooth muscle in primate esophagus tissue. These antibodies can be found in 60-70% of patients with Dermatitis herpetiformis (DH) on a non-restricted diet and in almost 100% of patients with Celiac disease (CD) and gluten-sensitivity enteropathy with partial or sub totaling villous atrophy. There is a small percentage of IgG EmA that will be negative IgA when screened. A negative result exhibited by a patient with overt clinical symptoms may need to be considered for IgG testing. It is recommended to perform an anti-Gliadin test in order to reach the maximum specificity of the test. It has been demonstrated that serum IgA endomysial antibodies were found in the majority (87%) of patients with untreated Celiac disease and approximately 70% of anti-Gliadin (IgA AGA) positive patients. The R1 anti-Reticulin (R1-ARA) appears to be a less reliable marker with less than 50% being positive. These findings were based on the same patient population. It should be noted that a strict adherence to a gluten-free diet will greatly effect the antibody results in most patients. IgA AGA and R1-ARA will normally disappear after one year while IgA EmA may persist at a lower titer. In this way the test may have prognostic value in monitoring strict adherence to diet.

Device Characteristics

Single Use
Yes
Prescription Use (Rx)
Yes
Over the Counter (OTC)
No
Kit
Yes
Combination Product
No
HCT/P
No
Contains NRL
No
Not Made with NRL
No
MRI Safety
Labeling does not contain MRI Safety Information
Direct Marking Exempt
No
PM Exempt
No
Has Serial Number
No
Has Lot/Batch Number
Yes
Has Manufacturing Date
No
Has Expiration Date
Yes
Has Donation ID
No

Sterilization

Is Sterile
No
Sterilization Prior Use
No

Product Codes

Code Name
MVM Autoantibodies, Endomysial(Tissue Transglutaminase)

GMDN Terms

Code Name
54905 Endomysium antibody (EMA) IVD, kit, fluorescent immunoassay

Identifiers

Type ID
Primary 00845533002011

Storage Conditions

Type
Storage Environment Temperature
Temperature Range
2 – 8 Degrees Celsius